In conventional colorectal adenocarcinoma, the rate of loss of E-cadherin expression was reported between 13.0%-41.7% and down-regulated E-cadherin expression predicted worse prognosis[29–32]. The gene discussed is CDH1; the disease is colorectal adenocarcinoma.